AI News, Partner Q&A: Snips Voice AI Platform artificial intelligence

Breaking News: Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator

Sponsored Content Release FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews.

The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies.

FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation.

FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print.

Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status.

Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator

There is a significant opportunity to advance a therapeutic solution to treat AK and address a patient population that contributes to 20% of all hospitalizations in the US2.  Current treatments for AKI are mainly supportive and do not treat the underlying condition3.

Mannin's Chief Scientific Officer, Dr. Susan Quaggin, presented data that showed that the Ang-Tie2 signaling pathway is a promising therapeutic target to prevent AKI after ischemia caused by ischemia–reperfusion (IR) injury to the kidney.  Ischemia in the kidney occurs in a range of clinically important scenarios such as hypotension, sepsis, and cardiovascular events such as strokes.

Taken together with our recently announced funding and establishment of a research center in Saxony, Germany, this data will enable us to advance our program in developing therapeutics to treat acute kidney injury, bolstering our pipeline,' said Dr. Nikopoulos.

Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price.

We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator

There is a significant opportunity to advance a therapeutic solution to treat AK and address a patient population that contributes to 20% of all hospitalizations in the US2.  Current treatments for AKI are mainly supportive and do not treat the underlying condition3.

Mannin's Chief Scientific Officer, Dr. Susan Quaggin, presented data that showed that the Ang-Tie2 signaling pathway is a promising therapeutic target to prevent AKI after ischemia caused by ischemia–reperfusion (IR) injury to the kidney.  Ischemia in the kidney occurs in a range of clinically important scenarios such as hypotension, sepsis, and cardiovascular events such as strokes.

Taken together with our recently announced funding and establishment of a research center in Saxony, Germany, this data will enable us to advance our program in developing therapeutics to treat acute kidney injury, bolstering our pipeline,"

Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price.

We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Actionable AI insights using Translation and Natural Language (Cloud Next '19)

Using Google machine learning, customers leverage Cloud Translation to dynamically translate between languages and Cloud Natural Language to derive ...

Machine Learning Magic for Your JavaScript Application (Google I/O'19)

TensorFlow.js is a library for training and deploying machine learning models in the browser and in Node.js and offers unique opportunities for JavaScript ...

Custom Voice Update : Build 2018

We are releasing a new service in Preview that allows you to create Custom Voice fonts. Come learn about the new service as well as the new features of the ...

Monica Lam: Privacy in the age of virtual assistants

Read more: Can we reap the benefits of artificial intelligence while also protecting our personal information? From scheduling ..

Run AI powered apps on the edge with Azure Data Box Edge - BRK3065

Learn how you can use Data Box Edge with built-in FPGAs to deliver accelerated intelligence at the edge - all controlled and managed from Azure. We'll demo ...

Amy Webb | SXSW 2019

2019 Emerging Tech Trends Report You've undoubtedly studied trends within your own industry, but how can you prepare yourself and your business for what's ...

On parle Intelligence Artificielle avec le COO de Snips

C'est un épisode spécial que je vous propose mes amis puisque j'ai Yann Lechelle le COO de Snips en invité ! COO de Snips mais aussi membre de l'Insead ...

Science and innovation for sustainability transformation strategies (1/6)

Dr Bernard Meyerson, Chief Innovation Officer at IBM, presents a keynote arguing that sustainability, in the broadest sense, is driven by science, technology and ...

How to Optimize Your Content Curation Efforts with Video Featuring Lumen5 (Webinar Replay)

Learn how to take your content curation efforts to the next level using video–without having to invest in expensive software or equipment or spend more than five ...

Speaking Naturally to Computers: Success in Consumer & Business

Lab to Live - Speaking Naturally to Computers: Success in Consumer & Business Jess Williams; Co-founder, Opearlo Catherine Breslin; Solutions Architect, ...